Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60760-734

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60760-734 (Atorvastation 60760 734 30)

60760-734 (Atorvastation 60760 734 30)
This is not-readable.*
FDA Label Image

Chemical Structure (Chemical Structure)

FDA Label Image

Figure 1.jpg (Figure1)

FDA Label Image

Figure 2.jpg (Figure2)

Figure 2.jpg (Figure2)
This text provides information on a hazard ratio of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. It also mentions data on cumulative hazard (%) at 10 and 15, and the time to the first primary endpoint through four years of follow-up.*
FDA Label Image

Figure 3.jpg (Figure3)

Figure 3.jpg (Figure3)
This is a statistical analysis comparing the effects of two different doses of atorvastatin on the time to the first major cardiovascular event. The text shows that the higher dose of atorvastatin (80 mg) demonstrated a hazard ratio of 0.78 and a statistically significant P value of 0.0002 compared to the lower dose (10 mg). This data could be useful for understanding the impact of different doses of atorvastatin on the occurrence of major cardiovascular events over time.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.